PharmaCyte Biotech, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

PharmaCyte Biotech, Inc. reported Cash And Cash Equivalents At Carrying Value of $15.17 million for the year ending 2025.

  • PharmaCyte Biotech, Inc. showed a decrease of -69.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from PharmaCyte Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on August 11, 2025.
  • XBRL data for this metric is available from 2010 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2010 to 2025), PharmaCyte Biotech, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,118,917.2%.
  • Historical annual values: Fiscal year 2025: $15.17 million | Fiscal year 2024: $50.18 million | Fiscal year 2023: $68.04 million | Fiscal year 2022: $85.40 million | Fiscal year 2013: $199.3 thousand | Fiscal year 2012: $15.7 thousand | Fiscal year 2011: $57.2 thousand | Fiscal year 2010: $716.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: